Earnings summaries and quarterly performance for PROASSURANCE.
Executive leadership at PROASSURANCE.
Edward Rand Jr.
President and Chief Executive Officer
Dana Hendricks
Executive Vice President and Chief Financial Officer
Jeffrey Lisenby
Executive Vice President, General Counsel & Secretary
Kevin Shook
President, Eastern Alliance Insurance Group
Robert Francis
President, Medical Professional Liability
Board of directors at PROASSURANCE.
Bruce Angiolillo
Chairman of the Board
Fabiola Cobarrubias
Director
Katisha Vance
Director
Maye Head Frei
Director
Richard Bielen
Director
Sam Di Piazza Jr.
Vice Chairman of the Board; Director
Scott Syphax
Director
Staci Pierce
Director
Research analysts who have asked questions during PROASSURANCE earnings calls.
Jon Paul Newsome
Piper Sandler & Co.
4 questions for PRA
Mark Hughes
Truist Securities
4 questions for PRA
Matthew Carletti
Citizens JMP Securities
4 questions for PRA
C. Gregory Peters
Raymond James
3 questions for PRA
Robert Farnam
Boenning & Scattergood
3 questions for PRA
Maxwell Fritscher
Truist Financial Corporation
1 question for PRA
Sidney Schultz
Raymond James
1 question for PRA
Recent press releases and 8-K filings for PRA.
- ProAssurance Corp reported a sharp decline in earnings for the third quarter of 2025, with net income plunging over 90% to $1.44 million, or $0.03 per share, significantly missing analyst expectations.
- Despite the profit decline, the company's third-quarter revenue of $279.55 million was only down 2% year-over-year, and it saw an 8.5% increase in investment income and an 8% rise in specialty property and casualty premium rates.
- ProAssurance is preparing for a major merger with The Doctors Company, which is expected to close by June 2026, aiming to strengthen its position amid industry challenges.
- The company's stock has risen approximately 45% over the past year, outperforming the S&P 500's 16.5% gain, reflecting investor confidence despite the earnings miss.
- ProAssurance Corporation reported net income of $1.4 million, or $0.03 per diluted share, for the three months ended September 30, 2025.
- Operating income for the third quarter of 2025 was $7.9 million, or $0.15 per diluted share.
- Total revenues for Q3 2025 amounted to $279.6 million.
- The consolidated combined ratio for the quarter ended September 30, 2025, was 114.7%.
- As of September 30, 2025, shareholders' equity stood at $1,304.3 million, with book value per share at $25.37.
- For the three months ended September 30, 2025, ProAssurance reported net income of $1.4 million, or $0.03 per diluted share, and operating income of $7.9 million, or $0.15 per diluted share.
- Consolidated net premiums written were $261.3 million for the third quarter of 2025.
- The consolidated Non-GAAP combined ratio was 112.2% in the third quarter of 2025, with the Specialty P&C segment at 109.1%.
- Book value per share was $25.37 at September 30, 2025, an increase from $23.49 at year-end 2024.
- The transaction with The Doctors Company is currently anticipated to close by June 30, 2026, pending regulatory approvals in California, Pennsylvania, and Texas.
Quarterly earnings call transcripts for PROASSURANCE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more